Official 2024 U.S. DOL Form 5500 summary for Adare Pharmaceuticals, INC. (Adare Pharmaceuticals, INC. 401(k) Plan · EIN 31-0988732 · PN 003): $69.10M net assets, 491 active participants, and $17.64 per $10,000 (17.64 bps).
| Plan Sponsor | Adare Pharmaceuticals, INC. |
|---|---|
| Filing Identifier | Adare Pharmaceuticals, INC. 401(k) Plan · EIN 31-0988732 · PN 003 |
| Plan Category & State | 401(k) Defined Contribution (NJ) |
| Asset-Size Peer Cohort | $25M-$100M |
| Plan Net Assets (2024) | $69.10M |
| Active Participants | 491 |
| Direct Admin Fee Rate | $17.64 per $10,000 (17.64 bps) |
| Cohort Peer Median | $19.23 per $10,000 (19.23 bps) |
| Primary Recordkeeper / Provider | Fidelity Investments |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($417,816, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI